Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)
Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%
Oramed Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Oramed Pharmaceuticals's market cap was $170.63M on Nov 11, 2026, against $116.39M a year earlier. Over the last 5 years it ranged from $70.23M to $504.00M, with a median of $120.65M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $170.63M | +46.6% |
| 2025 | Dec 31, 2025 | $116.39M | +19.6% |
| 2024 | Dec 31, 2024 | $97.31M | +4.6% |
| 2023 | Dec 29, 2023 | $93.05M | -78.1% |
| 2022 | Dec 30, 2022 | $424.59M | -15.8% |
| 2021 | Dec 31, 2021 | $504.00M | +402.1% |
| 2020 | Dec 31, 2020 | $100.38M | +12.1% |
| 2019 | Dec 31, 2019 | $89.52M | +71.8% |
| 2018 | Dec 31, 2018 | $52.11M | -57.6% |
| 2017 | Dec 29, 2017 | $123.02M | +52.5% |
| 2016 | Dec 30, 2016 | $80.68M | -18.4% |
| 2015 | Dec 31, 2015 | $98.86M | +114.6% |
| 2014 | Dec 31, 2014 | $46.07M | -62.4% |
| 2013 | Dec 31, 2013 | $122.48M | +363.4% |
| 2012 | Dec 31, 2012 | $26.43M | +34.6% |
| 2011 | Dec 30, 2011 | $19.63M | – |
See a number that looks wrong?